GBIO

Generation Bio Co

Sep 17 • 04:00PM ET

5.77

-0.18 -3.03 %

Healthcare • Biotechnology • USA • NASD

Peers: NTLA CRSP EDIT BEAM SGMO SRPT BLUE PSTX IOVA ADVM

Index	-	P/E	-	EPS (ttm)	-10.83	Insider Own	31.38%	Shs Outstand	6.73M	Perf Week	-3.51%
Market Cap	38.87M	Forward P/E	-	EPS next Y	-2.88	Insider Trans	0.00%	Shs Float	4.62M	Perf Month	-12.97%
Enterprise Value	-17.17M	PEG	-	EPS next Q	-3.15	Inst Own	44.89%	Short Float	4.23%	Perf Quarter	51.05%
Income	-72.42M	P/S	1.83	EPS this Y	57.21%	Inst Trans	-16.79%	Short Ratio	0.54	Perf Half Y	3.02%
Sales	21.23M	P/B	0.72	EPS next Y	66.04%	ROA	-32.57%	Short Interest	0.20M	Perf YTD	-45.57%
Book/sh	8.03	P/C	0.27	EPS next 5Y	73.34%	ROE	-85.45%	52W High	29.10 -80.17%	Perf Year	-77.81%
Cash/sh	20.99	P/FCF	-	EPS past 3/5Y	2.26% -8.29%	ROIC	-55.85%	52W Low	3.00 92.08%	Perf 3Y	-89.21%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	78.21%	Volatility	6.23% 5.58%	Perf 5Y	-98.06%
Dividend TTM	-	EV/Sales	-0.81	EPS Y/Y TTM	54.71%	Oper. Margin	-346.11%	ATR (14)	0.40	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.51	Sales Y/Y TTM	61.15%	Profit Margin	-341.12%	RSI (14)	50.66	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.51	EPS Q/Q	-1.63%	SMA20	-4.37%	Beta	2.54	Target Price	11.00
Payout	-	Debt/Eq	1.58	Sales Q/Q	-81.30%	SMA50	10.17%	Rel Volume	0.09	Prev Close	5.95
Employees	115	LT Debt/Eq	1.40	Earnings	Aug 12 AMC	SMA200	-5.22%	Avg Volume	362.19K	Price	5.77
IPO	Jun 12, 2020	Option/Short	No / Yes	EPS/Sales Surpr.	-9.53% -69.53%	Trades		Volume	30,935	Change	-3.03%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-13-25	Downgrade	Wedbush	Outperform → Neutral	$7
Oct-19-23	Downgrade	TD Cowen	Outperform → Market Perform
Nov-08-22	Initiated	Canaccord Genuity	Buy	$9
Dec-14-21	Downgrade	William Blair	Outperform → Mkt Perform
Jun-08-21	Initiated	JMP Securities	Mkt Outperform	$40
Feb-24-21	Initiated	William Blair	Outperform
Feb-18-21	Initiated	Needham	Buy	$50
Jul-07-20	Initiated	Wedbush	Outperform	$31
Jul-07-20	Initiated	JP Morgan	Overweight	$28
Jul-07-20	Initiated	Jefferies	Buy	$38
Jul-07-20	Initiated	Cowen	Outperform

Show Previous Ratings

Aug-15-25 07:20AM	Precigen wins immunotherapy approval; Pfizer sickle cell drug fails trial (BioPharma Dive) -5.56%
Aug-12-25 05:30PM	Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates (Zacks) +63.21%
04:05PM	Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results (GlobeNewswire)
03:00PM	Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
Jul-18-25 08:35AM	Generation Bio Announces 1-for-10 Reverse Stock Split (GlobeNewswire) -22.08%
04:05PM	Loading…
Jul-07-25 04:05PM	Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +6.94%
May-28-25 06:59AM	Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference (GlobeNewswire)
May-07-25 05:35PM	Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -7.77%
04:05PM	Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results (GlobeNewswire)
Apr-02-25 06:59AM	Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference (GlobeNewswire)
Mar-13-25 05:15PM	Generation Bio Co. (GBIO) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -6.25%
04:05PM	Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-24-25 06:59AM	Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference (GlobeNewswire)
Jan-06-25 04:30PM	Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases (GlobeNewswire) -8.77%
Nov-06-24 05:40PM	Generation Bio Co. (GBIO) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +9.59%
04:05PM	Loading…
04:05PM	Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-22-24 06:59AM	Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress (GlobeNewswire)
Sep-12-24 04:05PM	Generation Bio to Present at the 2024 Cantor Global Healthcare Conference (GlobeNewswire)
Aug-07-24 11:54PM	GBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q2 2024 (InvestorPlace) -9.39% +8.11%
07:35PM	Generation Bio Co. (GBIO) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Generation Bio Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-06-24 06:59AM	Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire) +7.46%
Jun-14-24 06:59AM	Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit (GlobeNewswire) -19.88%
Jun-03-24 04:30PM	Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now? (Insider Monkey)
04:17PM	9 Best Gene Therapy Stocks to Buy Now (Insider Monkey)
May-25-24 11:10PM	20 Biggest Publicly Traded Biotech Companies (Insider Monkey)
May-13-24 09:54PM	GBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace) -5.02% +24.65%
05:15PM	Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results (GlobeNewswire)
May-09-24 06:59AM	Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting (GlobeNewswire) +5.16%
10:49AM	Loading…
May-04-24 10:49AM	Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-22-24 05:31PM	Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting (GlobeNewswire) +16.01%
Apr-02-24 06:59AM	Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-08-24 04:32AM	Generation Bio Co Reports Full Year and Q4 2023 Financial Outcomes (GuruFocus.com) +18.98%
Mar-06-24 10:52PM	GBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) +6.50%
05:40PM	Generation Bio Co. (GBIO) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:20PM	Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-27-24 06:59AM	Generation Bio to Present at the 2024 TD Cowen Health Care Conference (GlobeNewswire) +6.79%
Jan-03-24 04:05PM	Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-06-23 03:05AM	Director Rowland Charles A Jr Acquires 342,960 Shares of Generation Bio Co (GBIO) (GuruFocus.com) +24.81%
Nov-29-23 08:41AM	Generation Bio eliminates 40% of staff, including 2 C-suite execs, in pivot to ex-liver targets (FierceBiotech.com)
06:59AM	Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms (GlobeNewswire)
Nov-09-23 04:15PM	Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results (GlobeNewswire) -11.11% +10.58%
Oct-26-23 06:59AM	Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform (GlobeNewswire)
Oct-18-23 06:59AM	Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel Immune-Quiet DNA (GlobeNewswire) -22.51%
Sep-19-23 07:30AM	Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit (GlobeNewswire)
Aug-03-23 08:49AM	Insider Buyers Lose US$80k As Generation Bio Sheds US$37m (Simply Wall St.)
07:30AM	Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire)
Aug-02-23 07:05PM	Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -5.49%
04:15PM	Generation Bio Reports Second Quarter 2023 Financial Results (GlobeNewswire)
May-31-23 07:30AM	Generation Bio to Present at the 2023 Jefferies Healthcare Conference (GlobeNewswire) -7.41%
May-10-23 06:05PM	Generation Bio Co. (GBIO) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -7.29%
04:15PM	Generation Bio Reports Business Highlights and First Quarter 2023 Financial Results (GlobeNewswire)
May-09-23 04:15PM	Generation Bio to Present at the JMP Securities Life Sciences Conference (GlobeNewswire)
Apr-11-23 07:30AM	Generation Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire) +7.21%
Apr-10-23 09:40AM	Here's Why We're Not At All Concerned With Generation Bio's (NASDAQ:GBIO) Cash Burn Situation (Simply Wall St.)
Apr-05-23 07:30AM	Generation Bio Appoints Yalonda Howze, J.D. as Chief Legal Officer (GlobeNewswire)
Mar-24-23 03:02PM	Moderna (MRNA) Inks Genetic Medicines Deal With Generation Bio (Zacks)
Mar-23-23 10:43AM	Moderna, Generation Bio Collaborate To Develop Non-Viral Genetic Medicines (Benzinga) +28.87%
07:29AM	UPDATE 2-Moderna signs licensing deal with Generation Bio in push beyond COVID (Reuters)
07:00AM	Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines (GlobeNewswire)
Mar-21-23 04:15PM	Generation Bio to Participate in the BMO Biopharma Spotlight Series: Novel Technologies for the Delivery of Genetic Medicines (GlobeNewswire)
Feb-27-23 07:30AM	Generation Bio to Present at the 43rd Annual Cowen Healthcare Conference (GlobeNewswire)
Feb-24-23 07:18AM	Bullish insiders bet US$536k on Generation Bio Co. (NASDAQ:GBIO) (Simply Wall St.) -9.44%
Feb-23-23 04:28PM	Generation Bio Outlines 2023 Strategic Priorities and Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Jan-03-23 04:30PM	Generation Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +26.68%
Dec-05-22 09:55AM	Can Generation Bio Co. (GBIO) Climb 184% to Reach the Level Wall Street Analysts Expect? (Zacks) -12.85%
Nov-17-22 09:55AM	Wall Street Analysts Think Generation Bio Co. (GBIO) Could Surge 176%: Read This Before Placing a Bet (Zacks)
Nov-03-22 04:15PM	Generation Bio Reports Business Highlights and Third Quarter 2022 Financial Results (GlobeNewswire) +12.88%
Nov-01-22 08:07AM	We're Hopeful That Generation Bio (NASDAQ:GBIO) Will Use Its Cash Wisely (Simply Wall St.) +9.57%
Sep-22-22 07:30AM	Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit (GlobeNewswire)
Sep-20-22 07:30AM	Generation Bio Names Phillip Samayoa, Ph.D. Chief Strategy Officer (GlobeNewswire)
Sep-17-22 08:12AM	A number of insiders bought Generation Bio Co. (NASDAQ:GBIO) stock last year, which is great news for shareholders (Simply Wall St.)
Aug-04-22 05:45PM	Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates (Zacks) +7.33%
04:15PM	Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-02-22 04:15PM	Generation Bio to Present at the 2022 Wedbush PacGrow Healthcare Conference (GlobeNewswire) +17.55%
Jul-18-22 07:30AM	Generation Bio Appoints Dannielle Appelhans to Its Board of Directors (GlobeNewswire) -5.99%
Jul-11-22 09:55AM	Wall Street Analysts See a 174% Upside in Generation Bio Co. (GBIO): Can the Stock Really Move This High? (Zacks) -8.54%
Jun-21-22 08:30AM	Generation Bio Announces Update to Its GMP Manufacturing Strategy (GlobeNewswire) +10.02%
Jun-02-22 07:30AM	Generation Bio to Present at the 2022 Jefferies Healthcare Conference (GlobeNewswire)
May-25-22 06:37AM	Here's Why We're Not Too Worried About Generation Bio's (NASDAQ:GBIO) Cash Burn Situation (Simply Wall St.)
May-05-22 07:05PM	Generation Bio Co. (GBIO) Reports Q1 Loss, Lags Revenue Estimates (Zacks) -9.17% -11.65%
04:15PM	Generation Bio Reports Business Highlights and First Quarter 2022 Financial Results (GlobeNewswire)
Apr-05-22 07:30AM	Generation Bio to Participate in 21st Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-25-22 12:00PM	Generation Bio Co. (GBIO) Upgraded to Buy: Here's Why (Zacks)
10:00AM	How Much Upside is Left in Generation Bio Co. (GBIO)? Wall Street Analysts Think 505% (Zacks)
Mar-02-22 07:30AM	Generation Bio to Participate in 42nd Annual Cowen Health Care Conference (GlobeNewswire)
Feb-24-22 04:20PM	Generation Bio Outlines 2022 Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results (GlobeNewswire) +9.09% +10.96%
Feb-10-22 07:30AM	Generation Bio Promotes Antoinette Paone, M.S., MBA to Chief Operating Officer (GlobeNewswire) -11.51%
Jan-05-22 07:30AM	Generation Bio to Present at 40th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -5.52%
Dec-28-21 07:37PM	SHAREHOLDER ALERT: Robbins LLP Investigates Generation Bio Co. (GBIO) on Behalf of Shareholders (Business Wire) -8.40%
Dec-19-21 09:37PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Generation Bio Co. - GBIO (GlobeNewswire)
Dec-16-21 11:02PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Generation Bio Co. - GBIO (PR Newswire) +9.67%
06:38PM	AWM Investment Company, Inc. Buys Destination XL Group Inc, LiqTech International Inc, Gambling. ... (GuruFocus.com)
07:01AM	Generation Bio (NASDAQ:GBIO) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Dec-14-21 06:30AM	Generation Bio Provides Update on Preclinical Studies for Hemophilia A Program (GlobeNewswire) -56.91%
12:38AM	AWM Investment Company, Inc. Buys Destination XL Group Inc, LiqTech International Inc, Gambling. ... (GuruFocus.com)
Nov-10-21 04:20PM	Generation Bio Reports Business Highlights and Third Quarter 2021 Financial Results (GlobeNewswire)
Oct-22-21 07:30AM	Generation Bio Presents Data Demonstrating First Lipid Nanoparticle to Achieve Uniform Retinal Transduction and Tolerability via Sub-Retinal Delivery of ceDNA and mRNA at the European Society of Gene and Cell Therapy 2021 Annual Virtual Congress (GlobeNewswire)
Oct-21-21 04:05PM	Generation Bio to Present at Jefferies Virtual Gene Therapy/Editing Summit (GlobeNewswire)

Generation Bio Co. is a genetic medicine company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Quinn Anthony G.	Director	Jan 10 '25	Buy	0.96	125,791	120,759	214,286	Jan 14 04:05 PM
Quinn Anthony G.	Director	Jan 13 '25	Buy	0.97	85,000	82,450	299,286	Jan 14 04:05 PM
Howze Yalonda	CHIEF LEGAL OFFICER	Oct 15 '24	Option Exercise	2.42	3,347	8,100	15,169	Oct 17 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GBIO

Generation Bio Co

Upgrade your FINVIZ experience